Strategic Partnerships Leverage ICS and Alloga as part of the Cencora family to approach pharmaceutical manufacturers seeking integrated 3PL and logistics services across North America and Europe; emphasize expanded distribution capabilities for high-demand therapies like CAR-T products and specialty medicines.

Technology Enablement Highlight the tech stack including Oracle, ServiceNow, Azure, New Relic, and Genesys to position as a modern, scalable logistics partner; offer value in data integration, real-time monitoring, and HR service delivery for improved customer experience and operations.

Regulatory & Compliance Readiness With a large pharmaceutical client base and recent high-stakes deals, present capabilities around compliance, traceability, cold chain management, and audit readiness to attract manufacturers requiring robust regulatory support.

Financial Growth Signals Cencora’s Q2 2026 revenue and margin expansion suggest a financially stable platform; pitch opportunities to onboard mid-to-large pharma clients seeking reliable scale and cost efficiencies in distribution and 3PL services.

Expansion Opportunities Recent partnerships and growth in CAR-T therapy distribution indicate an openness to expanding service lines and geographies; target biotech and pharma companies with niche therapies that require specialized 3PL, patient access programs, and global distribution support.